NCT03957083View on ClinicalTrials.gov

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

February 3, 2020

Study Completion Date

February 4, 2020

Conditions
Postpartum HemorrhageObesity
Interventions
DRUG

Oxytocin

Oxytocin administered intravenously, over 1 minute following delivery of the fetal head

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT03957083 - Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2 | Biotech Hunter | Biotech Hunter